Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 385


Epicardial implantable cardioverter-defibrillator system placed in a 4.9-kg infant.

Bryant R 3rd, Aboutalebi A, Kim JJ, Kertesz N, Morales DL.

Tex Heart Inst J. 2011;38(4):421-3.


Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.

Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.

Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.


Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.

Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV.

Circ Arrhythm Electrophysiol. 2014 Feb;7(1):164-70. doi: 10.1161/CIRCEP.113.001217. Epub 2014 Jan 20. Review.


Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.

Boriani G, Braunschweig F, Deharo JC, Leyva F, Lubinski A, Lazzaro C.

Europace. 2013 Oct;15(10):1453-62. doi: 10.1093/europace/eut133. Epub 2013 May 21.


Automatic external defibrillator, life vest defibrillator, or both?

Richard Conti C.

Clin Cardiol. 2010 Dec;33(12):722-3. doi: 10.1002/clc.20860.


Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.

Klein HU, Goldenberg I, Moss AJ.

Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31. Review.


Implantable cardioverter-defibrillator lead failure: how weak is the link?

Brinker JA.

Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):758-9. doi: 10.1038/ncpcardio1367. Epub 2008 Oct 7.


Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).

Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.

Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.


The wearable cardioverter-defibrillator: current technology and evolving indications.

Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU; EHRA Scientific Documents Committee (as external reviewers):, Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Blomström-Lundqvist C, Savelieva I.

Europace. 2017 Mar 1;19(3):335-345. doi: 10.1093/europace/euw180. Review.


Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy.

DeWitt ES, Triedman JK, Cecchin F, Mah DY, Abrams DJ, Walsh EP, Gauvreau K, Alexander ME.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1057-63. doi: 10.1161/CIRCEP.114.001569. Epub 2014 Sep 27.


Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.


Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.

Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M; Israeli Working Group on Pacing and Electrophysiology.

Europace. 2014 Aug;16(8):1175-80. doi: 10.1093/europace/euu015. Epub 2014 Feb 19.


The evolution and revolution of the implantable cardioverter defibrillator.

Indik JH.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):461-4. No abstract available.


Implantable cardioverter-defibrillators: indications and unresolved issues.

Kedia R, Saeed M.

Tex Heart Inst J. 2012;39(3):335-41. Review.


[Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].

Roche NC, Stefuriac M, Dumitrescu N, Charbonnel A, Godreuil C, Bonnevie L.

Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):27-31. doi: 10.1016/j.ancard.2014.08.018. Epub 2014 Sep 18. French.


Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.

Stefano B, Pietro RR, Maurizio G, Maurizio L, Renato M, Maurizio L, Pietro R, Alessandro P, Gianluca B, Monica M, Sergio C, Massimo S.

Am Heart J. 2011 Aug;162(2):390-7. doi: 10.1016/j.ahj.2011.04.008. Epub 2011 Jul 7.


Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.

Yoda M, Tanabe H, Kishi M, Suma H.

Interact Cardiovasc Thorac Surg. 2011 Apr;12(4):628-30. doi: 10.1510/icvts.2010.260521. Epub 2011 Jan 10.


Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.

Groh WJ, Foreman LD, Zipes DP.

Am Fam Physician. 1998 Jan 15;57(2):297-307, 310-2. Review.


HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L.

Circulation. 2014 Jul 1;130(1):94-125. doi: 10.1161/CIR.0000000000000056. Epub 2014 May 9. No abstract available.

Supplemental Content

Support Center